Related Experiment Videos
Cerebroprotective effects of diquertin and ascorbic acid
M B Plotnikov1, S V Logvinov, N V Pugachenko
1Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Science, Russia. oal@pharm.tsu.ru
Bulletin of Experimental Biology and Medicine
|February 22, 2001
Summary
This study shows that diquertin and ascorbic acid can reduce brain damage caused by experimental cerebral ischemia in rats. These compounds help protect the brain cortex from structural and functional changes due to circulatory issues.
Area of Science:
- Neuroscience
- Pathology
- Pharmacology
Background:
- Experimental cerebral ischemia leads to significant structural and functional brain cortex changes.
- Circulatory disturbances are a primary cause of ischemic brain damage.
Purpose of the Study:
- To investigate the neuroprotective effects of diquertin and ascorbic acid.
- To evaluate the attenuation of ischemic damage in the brain cortex.
Main Methods:
- Utilized electron microscopy for structural analysis.
- Employed electrophysiological studies for functional assessment.
- Administered diquertin and ascorbic acid repeatedly in a rat model of cerebral ischemia.
Main Results:
- Observed pronounced structural alterations in the brain cortex following experimental ischemia.
- Detected significant functional deficits in the brain cortex.
- Demonstrated that repeated administration of diquertin and ascorbic acid significantly attenuated ischemic damage.
Conclusions:
- Diquertin and ascorbic acid exhibit neuroprotective properties against ischemic injury.
- These compounds offer a potential therapeutic strategy for mitigating brain damage from circulatory disturbances.